Let's keep the eyes on the ball :) So, we have
Post# of 148173
(Total Views: 559)
Posted On: 04/13/2020 9:13:25 AM
Let's keep the eyes on the ball 
So, we have 25 patients treated under EIND. This is exactly what we want to hear. More and more hospitals and doctors are adopting Leronlimab, with clusters in Montifiori (N.Y.) and Southern California. I expect this number to grow larger this wek to the point that we will lose control of what comes from where.
Which is what happens with a successful drug.
We know for sure that 7 in New York and 5 in Southern are doing well. Of course, this is a combination of Severe (mostly in N.Y.) and Mild to Moderate (California). So no conclusions can be drawn as, surely, there will be more improving (4 more removed from oxygen probably will completely recover as well). Only conclusion is that the drug is helping big time.
Also, recruitment for the Mild to Moderate P2 is ongoing full speed in Montefiori and we have already 12 patients as last week. I suspect we will have full recruitment (75 patients) by beginning of next week (More than 25 hospitals, to date, have requested participation in the Company’s trials). Clock will be ticking for the 14 days time-frame evaluation.
And, mark the date for recruitment of P2b/3 Severe enrollments. We will be getting some updates soon. We are on our way …
Just great news to start a very eventful week.
So, we have 25 patients treated under EIND. This is exactly what we want to hear. More and more hospitals and doctors are adopting Leronlimab, with clusters in Montifiori (N.Y.) and Southern California. I expect this number to grow larger this wek to the point that we will lose control of what comes from where.
Which is what happens with a successful drug.
We know for sure that 7 in New York and 5 in Southern are doing well. Of course, this is a combination of Severe (mostly in N.Y.) and Mild to Moderate (California). So no conclusions can be drawn as, surely, there will be more improving (4 more removed from oxygen probably will completely recover as well). Only conclusion is that the drug is helping big time.
Also, recruitment for the Mild to Moderate P2 is ongoing full speed in Montefiori and we have already 12 patients as last week. I suspect we will have full recruitment (75 patients) by beginning of next week (More than 25 hospitals, to date, have requested participation in the Company’s trials). Clock will be ticking for the 14 days time-frame evaluation.
And, mark the date for recruitment of P2b/3 Severe enrollments. We will be getting some updates soon. We are on our way …
Just great news to start a very eventful week.
(7)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼